Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study.
Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, Entrenas-Castillo M, Perez-Caballero AI, López-Carmona MD, Garcia-Alegria J, Lozano Rodríguez-Mancheño A, Arenas-de Larriva MDS, Pérez-Belmonte LM, Jungreis I, Bouillon R, Quesada-Gomez JM, Lopez-Miranda J. Alcala-Diaz JF, et al. Nutrients. 2021 May 21;13(6):1760. doi: 10.3390/nu13061760. Nutrients. 2021. PMID: 34064175 Free PMC article. Clinical Trial.
Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care).
Bernal-Lopez MR, Villalobos-Sanchez A, Mancera-Romero J, Jansen-Chaparro S, Baca-Osorio AJ, Lopez-Carmona MD, Tinahones FJ, Gomez-Huelgas R. Bernal-Lopez MR, et al. Diabetes Res Clin Pract. 2011 Aug;93(2):e57-e60. doi: 10.1016/j.diabres.2011.02.024. Epub 2011 Mar 21. Diabetes Res Clin Pract. 2011. PMID: 21420192
Efficacy and safety of replacing sitagliptin with canagliflozin in real-world patients with type 2 diabetes uncontrolled with sitagliptin combined with metformin and/or gliclazide: The SITA-CANA Switch Study.
Garcia de Lucas MD, Pérez Belmonte LM, Suárez Tembra M, Olalla Sierra J, Gómez Huelgas R. Garcia de Lucas MD, et al. Diabetes Metab. 2018 Sep;44(4):373-375. doi: 10.1016/j.diabet.2018.05.005. Epub 2018 May 22. Diabetes Metab. 2018. PMID: 29859992
Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study).
Pérez-Belmonte LM, Gómez-Doblas JJ, Millán-Gómez M, López-Carmona MD, Guijarro-Merino R, Carrasco-Chinchilla F, de Teresa-Galván E, Jiménez-Navarro M, Bernal-López MR, Gómez-Huelgas R. Pérez-Belmonte LM, et al. J Clin Med. 2018 Sep 11;7(9):271. doi: 10.3390/jcm7090271. J Clin Med. 2018. PMID: 30208631 Free PMC article.
332 results